Eris Lifesciences Pvt. Ltd filed a draft red herring prospectus with the capital markets regulator Securities and Exchange Board of India (SEBI) for an initial public offering (IPO) on Wednesday.
The IPO comprises an offer for sale (OFS) by the drug company’s private equity backer ChrysCapital and some of the founding shareholders.
Eris Lifesciences is the first pharmaceutical company to file its draft papers this year. The last pharmaceutical firm to go public was Warburg Pincus-backed Laurus Labs in November 2016. Before that, Alkem Laboratories went public in January 2016.
The IPO comprises an offer for sale (OFS) by the drug company’s private equity backer ChrysCapital and some of the founding shareholders.
Eris Lifesciences is the first pharmaceutical company to file its draft papers this year. The last pharmaceutical firm to go public was Warburg Pincus-backed Laurus Labs in November 2016. Before that, Alkem Laboratories went public in January 2016.
No comments:
Post a Comment